{"organizations": [], "uuid": "6c12a4d8e60a709f9d5ac9e44a16ed04857b2138", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180111.html", "section_title": "Archive News &amp; Video for Thursday, 11 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-endo-comments-on-us-attorneys-offi/brief-endo-comments-on-u-s-attorneys-office-grand-jury-subpoena-relating-to-products-containing-oxymorphone-idUSFWN1P60LE", "country": "US", "domain_rank": 408, "title": "BRIEF-Endo Comments On U.S. Attorney's Office Grand Jury Subpoena Relating To Products Containing Oxymorphone", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.327, "site_type": "news", "published": "2018-01-11T21:37:00.000+02:00", "replies_count": 0, "uuid": "6c12a4d8e60a709f9d5ac9e44a16ed04857b2138"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-endo-comments-on-us-attorneys-offi/brief-endo-comments-on-u-s-attorneys-office-grand-jury-subpoena-relating-to-products-containing-oxymorphone-idUSFWN1P60LE", "ord_in_thread": 0, "title": "BRIEF-Endo Comments On U.S. Attorney's Office Grand Jury Subpoena Relating To Products Containing Oxymorphone", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "florida", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "endo international plc", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - Endo International Plc:\n* ENDO COMMENTS ON UNITED STATES ATTORNEY‘S OFFICE GRAND JURY SUBPOENA RELATING TO PRODUCTS CONTAINING OXYMORPHONE\n* ENDO INTERNATIONAL - UNIT ENDO PHARMACEUTICALS RECEIVED GRAND JURY SUBPOENA FROM UNITED STATES ATTORNEY‘S OFFICE FOR SOUTHERN DISTRICT OF FLORIDA\n* ENDO - ‍SUBPOENA REQUESTS DISTRIBUTION,THIRD PARTY AGREEMENTS,DOCUMENTS ON INTERACTIONS WITH GOVERNMENT. AGENCIES RELATED TO PRODUCTS CONTAINING OXYMORPHONE​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-11T21:37:00.000+02:00", "crawled": "2018-01-12T18:32:06.003+02:00", "highlightTitle": ""}